Key result
Syncope occurs in 15-25% of patients with hypertrophic cardiomyopathy and is associated with an increased risk of sudden death in young patients, though the mechanism often remains unexplained.
Syncope is a common and potentially high-risk symptom in HCM that requires thorough investigation to identify treatable mechanisms such as arrhythmias.
No takes yet. Share an insight, caveat, or question.
Syncope in HCM warrants detailed evaluation for treatable causes; leaves open mechanisms and optimal sudden death risk stratification in young patients.
Williams et al. (2007) conducted a review in Hypertrophic cardiomyopathy. Syncope occurs in 15-25% of patients with hypertrophic cardiomyopathy and is associated with an increased risk of sudden death in young patients, though the mechanism often remains unexplained.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: